🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase 1a/1b does-escalation study of cabiralizumab alone and with nivolumab...
Status
Completed
Location
Scottsdale Healthcare Hospitals DBA Honor Health
Start Date
2015-09-08
Trial ID
NCT02526017
Treatments Being Tested
High-grade gliomas (HGGs) are among the most aggressive and treatment-resis...
Status
Recruiting
Location
Vanderbilt University Medical Center
Start Date
2026-03-27
Trial ID
NCT07210632
Treatments Being Tested
This phase II trial studies the side effects and how well nivolumab and ibr...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2019-02-15
Trial ID
NCT03770416
This is an open-label study to determine the safety, tolerability and immun...
Status
Completed
Location
Pusan National University Hospital
Start Date
2020-12-22
Trial ID
NCT04778904
Treatments Being Tested
Patients with relapsed or refractory follicular or marginal zone lymphoma w...
Status
Terminated
Location
University of Illinois Cancer Center
Start Date
2020-06-15
Trial ID
NCT04431635
Treatments Being Tested
This study is designed to evaluate the safety and tolerability of treatment...
Status
Completed
Location
The Angeles Clinic and Research Institute
Start Date
2019-01-28
Trial ID
NCT03817125
Treatments Being Tested
The purpose of the study is to capture the utilization of nivolumab among p...
Status
Completed
Location
Local Institution
Start Date
2020-08-13
Trial ID
NCT05068609
Treatments Being Tested
The prognosis of patients with "high-grade B cell lymphoma with cellular my...
Status
Active Not Recruiting
Location
BE-Antwerpen-ZNASTUIVENBERG
Start Date
2018-08-01
Trial ID
NCT03620578
Treatments Being Tested
This proof of concept trial aims to assess whether the combination of IRE w...
Status
Terminated
Location
Lindenhofspital
Start Date
2020-06-28
Trial ID
NCT04212026
Treatments Being Tested
Response Rate...
Status
Completed
Location
University of Southern California
Start Date
2013-11-06
Trial ID
NCT01928576
Treatments Being Tested